HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
MOVE
Movano Inc.
MOVE lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
MOVE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
MOVE's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
MOVE PE Valuation
MOVE has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
MOVE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect MOVE's losses to shrink, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
MOVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$18.64 | +$10.13 |
| Q1 2026 | -$17.62 | +$16.05 |
| Q4 2025 | -$21.79 | +$19.58 |
| Q3 2025 | -$22.90 | +$25.20 |
| Q2 2025 | -$28.77 | +$35.73 |
| Q1 2025 | -$33.67 | +$47.33 |
| Q4 2024 | -$41.37 | +$53.13 |
| Q3 2024 | -$48.10 | +$67.40 |
MOVE has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over MOVE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over MOVE on profitability, with a higher operating margin.
MOVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5M | +6128% |
| Q2 2026 | $3.8M | +3590% |
| Q1 2026 | $510K | +148% |
| Q4 2025 | $44K | -60% |
| Q3 2025 | $80K | +60% |
| Q2 2025 | $103K | +348% |
| Q1 2025 | $206K | -76% |
MOVE's revenue is growing: $5M last quarter, up 6128% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -350% | +2889 points |
| Q2 2026 | -400% | +2765 points |
| Q1 2026 | -950% | +1592 points |
| Q4 2025 | -10032% | -5805 points |
| Q3 2025 | -3239% | +11519 points |
| Q2 2025 | -3165% | +24648 points |
| Q1 2025 | -2543% | -1867 points |
| Q4 2024 | -4227% | N/A |
MOVE's operating margin was −350% last quarter, up 2889 points from the same quarter a year ago, near the top of its range since 2024.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
MOVE has the stronger cash trend. Its trailing FCF is down 70% versus its history, compared with HIMS at down 84%.
MOVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2.3M | +$2.3M |
| Q4 2024 | -$4.6M | +$702K |
| Q3 2024 | -$5.7M | +$1.3M |
| Q2 2024 | -$8.2M | -$262K |
| Q1 2024 | -$4.1M | +$2M |
| Q4 2023 | -$5.3M | +$1.1M |
| Q3 2023 | -$7M | -$517K |
| Q2 2023 | -$7.9M | -$1.5M |
MOVE has burned cash in almost every quarter: −$35M over the past year, against −$23M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over MOVE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
MOVE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +54% | +878K shares |
| 1 year | +252% | +1.8M shares |
| 3 years | +1041% | +2.3M shares |
| 5 years | +17% | +365K shares |
MOVE has 3M diluted shares, up 252% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
MOVE Net Leverage
MOVE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
MOVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 1.9 | Oversold |
MOVE's weekly RSI is 36 (neutral) and its Stochastic is 2 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
MOVE PE vs Healthcare Sector
MOVE has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
MOVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 43% below |
| 20 week MA | $11.0 | 57% below |
| 50 week MA | $12.7 | 63% below |
| 100 week MA | $16.0 | 70% below |
| 200 week MA | $66.2 | 93% below |
MOVE is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
MOVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $846.0 | $447.0 | -47% |
| 2022 | $447.0 | $219.0 | -51% |
| 2023 | $219.0 | $117.2 | -46% |
| 2024 | $117.2 | $58.5 | -50% |
| 2025 | $58.5 | $8.14 | -86% |
| 2026 YTD | $8.14 | $4.71 | -42% |
MOVE has the edge over HIMS on returns for 2026, with the stronger performance.